Prevention of Cancer Associated Thrombosis - Shahid Gilani, MD

Shahid Gilani, MD, Specialist doctor in Clinical Oncology from University Hospital of North Midlands, speaks about the Cancer Associated Thrombo-prophylaxis.

Dedicated Cancer Associated Service

@UNHM_NHS

@sngilani

Prevention of Cancer Associated Thrombosis – Shahid Gilani, MD

FDA Approves Deciphera Vimseltinib / Romvimza for symptomatic tenosynovial giant cell tumor (TGCT) patients

FDA Approves Mirdametinib: Is this the Breakthrough NF1-PN Patients Have Been Waiting For?

Understanding and Managing BPDCN: Insights from Priyanka Meta’s Conference Presentation

Prevention of Cancer Associated Thrombosis – Shahid Gilani, MD

Related Posts

FDA Approves Deciphera Vimseltinib / Romvimza for symptomatic tenosynovial giant cell tumor (TGCT) patients

FDA Approves Mirdametinib: Is this the Breakthrough NF1-PN Patients Have Been Waiting For?

Understanding and Managing BPDCN: Insights from Priyanka Meta’s Conference Presentation